Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Marathon Asset Management
AddedFeb 13, 2024
UpdatedJun 28, 2026
Marathon Asset Management

Marathon Asset Management

Operating

Marathon Asset Management: A global credit and fixed income investment manager with diverse strategies.

Location
New York City, NY, US
Founded
1998
Firm
Compare
Portfolio
Fundraising
Employees
Website

Marathon Asset Management is a global investment manager specializing in credit and fixed income markets. The firm focuses on a variety of investment strategies, including private credit, direct lending, opportunistic credit, asset-based lending, and various forms of finance such as transportation, healthcare, and real estate. Marathon typically participates in private equity, post-IPO debt and equity rounds, and debt financing, managing a diverse portfolio of investment programs.

Notable portfolio companies include ADMA Biologics, Avenger Flight Group, Baudax Bio, Dermavant Sciences, Healogics, and Workhorse Group. Marathon's key partners and decision-makers bring extensive experience from leading financial institutions. The firm's investment philosophy emphasizes opportunistic investing and value creation through active management. Marathon also offers unique value-add services such as tailored financing solutions and strategic advisory to support the growth and success of its portfolio companies.

Marathon Asset Management - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments7
Current Portfolio Count7
Total Portfolio Exits0

Top Investment Stages

Post Ipo Debt2 (28.6%)
Private Equity2 (28.6%)
Debt Financing1 (14.3%)
Post Ipo Equity1 (14.3%)
Series C1 (14.3%)

Stage Mix

Post Ipo Debt 29%Private Equity 29%Debt Financing 14%Post Ipo Equity 14%Series C 14%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Mercury logo

Mercury

Avenger Flight Group logo

Avenger Flight Group

Dermavant Sciences logo

Dermavant Sciences

Healogics logo

Healogics

Baudax Bio logo

Baudax Bio

Workhorse Group logo

Workhorse Group

ADMA Biologics logo

ADMA Biologics

Marathon Asset Management - Similar Investment Firms

Marathon Venture Partners logo

Marathon Venture Partners

Marshall Wace logo

Marshall Wace

mwam.com

Apollo Global Management logo

Apollo Global Management

apollo.com

Amergin Asset Management logo

Amergin Asset Management

amerginam.com

Madryn Asset Management logo

Madryn Asset Management

madrynlp.com

J.P. Morgan Asset Management logo

J.P. Morgan Asset Management

MidOcean Partners logo

MidOcean Partners

ArrowMark Partners logo

ArrowMark Partners

Churchill Asset Management logo

Churchill Asset Management

churchillam.com

Wellington Management logo

Wellington Management

wellington.com

Medalist Partners logo

Medalist Partners

Marlin Equity Partners logo

Marlin Equity Partners

marlinequity.com

Millennium Management logo

Millennium Management

mlp.com

Deerfield Management logo

Deerfield Management

deerfield.com

Serengeti Asset Management logo

Serengeti Asset Management

serengeti-am.com

Marathon Asset Management - Classification

Also Known As
  • Marathon Asset Management, L.P.
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
Show 2 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
SIC
  • 6000Depository Institutions